We are live on ! Find out more
MP

MSD Partners Portfolio holdings

AUM $76.8M
1-Year Est. Return 34.91%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
-34.91%
3 Year Est. Return
+3.5%
5 Year Est. Return
-35.03%
10 Year Est. Return
+34.75%
AUM
$3.43B
AUM Growth
+$1.82B
Cap. Flow
-$423M
Cap. Flow %
-12.36%
Top 10 Hldgs %
90.22%
Holding
41
New
5
Increased
2
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
APO icon
Apollo Global Management
APO
+$9.2M
2
EGLT
Egalet Corporation
EGLT
+$1.42M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$469K
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$367K

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$131M
2
NXST icon
Nexstar Media Group
NXST
+$74.7M
3
FUN icon
Cedar Fair
FUN
+$66.8M
4
USFD icon
US Foods
USFD
+$54.6M
5
VST icon
Vistra
VST
+$34M

Sector Composition

Rank Sector Weight
1 Miscellaneous 68.36%
2 Technology 7.65%
3 Energy 6.19%
4 Communication Services 4.41%
5 Financials 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
26
Citigroup
C
$231B
$7.13M 0.21%
98,023
– –
EZPW icon
27
Ezcorp Inc
EZPW
$2.05B
$6.79M 0.2%
715,000
– –
TOVX icon
28
Theriva Biologics
TOVX
$11.6M
$3.84M 0.11%
471
– –
FCSC
29
DELISTED
Fibrocell Science Inc.
FCSC
$2.12M 0.06%
138,592
– –
EGLT
30
DELISTED
Egalet Corporation
EGLT
$1.36M 0.04%
+1,060,100
New +$1.42M
OGEN icon
31
Oragenics
OGEN
$2.3M
$724K 0.02%
96
– –
NBRV
32
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$410K 0.01%
+200
New +$469K
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$394K 0.01%
+25,000
New +$367K
ARMP icon
34
Armata Pharmaceuticals
ARMP
$217M
$14K ﹤0.01%
1,072
– –
CDZI icon
35
Cadiz
CDZI
$353M
– –
-336,699
Closed -$4.54M
KRNT icon
36
Kornit Digital
KRNT
$711M
– –
-103,300
Closed -$2M
USFD icon
37
US Foods
USFD
$22.5B
– –
-2,007,170
Closed -$54.6M
VST icon
38
Vistra
VST
$50.1B
– –
-2,024,921
Closed -$34M
VRTV
39
DELISTED
VERITIV CORPORATION
VRTV
– –
-28,383
Closed -$1.28M
NEOS
40
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-67,600
Closed -$493K
NYRT
41
DELISTED
New York REIT, Inc.
NYRT
– –
-74,680
Closed -$6.45M
1
2

Similar funds

MA
McGrath & Associates Asheville, North Carolina $76.8M AUM 22.42% 1-Year Est. Return
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $76.9M AUM
QM
QVIDTVM Management The Woodlands, Texas $76.6M AUM 33.48% 1-Year Est. Return
SWM
Stapp Wealth Management Olympia, Washington $76.5M AUM 21.17% 1-Year Est. Return
BC
Bayhunt Capital Mill Valley, California $77.1M AUM
VIM
VCU Investment Management Richmond, Virginia $77.1M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $76.2M AUM 9.17% 1-Year Est. Return
SRA
Summit Rock Advisors New York $76.1M AUM

MSD Partners's Q3 2017 Portfolio in Review

As of Q3 2017, MSD Partners held 41 positions worth $3.43B, up 113% from $1.61B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

MSD Partners withdrew a net $423M in Q3 2017, closing 7 positions and reducing 7 holdings. Its most notable exit was US Foods, an estimated $54.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 68% of assets, up from 8.1% a quarter earlier, followed by Technology and Energy.

Against the trend, MSD Partners opened a new position in Egalet Corporation worth $1.36M.

  • MSD Partners's largest Q3 2017 buy was Egalet Corporation: 1,060,100 shares worth $1.36M.
  • MSD Partners added most to Apollo Global Management in Q3 2017, an estimated $9.2M increase.
  • MSD Partners's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $131M.
  • MSD Partners fully exited US Foods in Q3 2017, selling an estimated $54.6M.
  • MSD Partners's ten largest holdings make up 90% of its $3.43B portfolio in Q3 2017.
  • MSD Partners opened 5 new positions and closed 7 in Q3 2017.
  • MSD Partners's portfolio value rose 113% quarter-over-quarter to $3.43B.

Based on MSD Partners's 13F filing for Q3 2017, filed 14 Nov 2017.